Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 23473937)

1.

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.

Couch Y, Martin CJ, Howarth C, Raley J, Khrapitchev AA, Stratford M, Sharp T, Sibson NR, Anthony DC.

Neuroimage. 2013 Jul 15;75:177-86. doi: 10.1016/j.neuroimage.2013.02.046. Epub 2013 Mar 5. Erratum in: Neuroimage. 2014 Jul 1;94:413.

2.

Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain.

Preece MA, Taylor MJ, Raley J, Blamire A, Sharp T, Sibson NR.

Neuroscience. 2009 Mar 17;159(2):751-9. doi: 10.1016/j.neuroscience.2008.12.032. Epub 2009 Jan 1.

PMID:
19174180
3.
4.

Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.

Udo de Haes JI, Cremers TI, Bosker FJ, Postema F, Tiemersma-Wegman TD, den Boer JA.

Neuropsychopharmacology. 2005 Sep;30(9):1624-31.

5.

Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.

Hume S, Hirani E, Opacka-Juffry J, Myers R, Townsend C, Pike V, Grasby P.

Synapse. 2001 Aug;41(2):150-9.

PMID:
11400181
6.

Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study.

McKie S, Richardson P, Elliott R, Völlm BA, Dolan MC, Williams SR, Anderson IM, Deakin JF.

Neuroimage. 2011 Sep 15;58(2):497-507. doi: 10.1016/j.neuroimage.2011.06.049. Epub 2011 Jun 25.

PMID:
21726650
7.
8.

Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.

Baumann MH, Ayestas MA, Dersch CM, Partilla JS, Rothman RB.

Ann N Y Acad Sci. 2000 Sep;914:172-86.

PMID:
11085319
9.

In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.

Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):315-22.

PMID:
9774218
10.

Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.

Liu YP, Wilkinson LS, Robbins TW.

Psychopharmacology (Berl). 2004 Apr;173(1-2):175-85. Epub 2004 Jan 15.

PMID:
14726995
11.

Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys.

Udo de Haes JI, Harada N, Elsinga PH, Maguire RP, Tsukada H.

Synapse. 2006 Jan;59(1):18-26.

PMID:
16237679
12.

The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM.

J Neurochem. 2009 Jun;109(5):1363-74. doi: 10.1111/j.1471-4159.2009.06050.x. Epub 2009 Mar 23.

PMID:
19476548
13.

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.

Ichikawa J, Kuroki T, Dai J, Meltzer HY.

Eur J Pharmacol. 1998 Jun 19;351(2):163-71.

PMID:
9686999
14.

Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Li JX, Unzeitig A, Javors MA, Rice KC, Koek W, France CP.

J Pharmacol Exp Ther. 2009 Nov;331(2):671-9. doi: 10.1124/jpet.109.157560. Epub 2009 Aug 17.

15.

A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.

Gonzalez LE, Parada MA, Tucci S, Teneud L, Overstreet DH, Hernandez L.

Braz J Med Biol Res. 2003 Feb;36(2):263-7. Epub 2003 Jan 29.

16.

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.

Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM.

J Neurochem. 2004 Apr;89(1):54-63.

PMID:
15030389
17.

Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.

Body S, Kheramin S, Ho MY, Miranda Herrera F, Bradshaw CM, Szabadi E.

Psychopharmacology (Berl). 2004 Nov;176(2):154-65. Epub 2004 Apr 22.

PMID:
15103450
18.

Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.

McCreary AC, Filip M, Cunningham KA.

Behav Neurosci. 2003 Apr;117(2):212-21.

PMID:
12708517
20.

5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.

Hasegawa S, Fikre-Merid M, Diksic M.

Brain Res Bull. 2012 Jan 4;87(1):44-9. doi: 10.1016/j.brainresbull.2011.10.009. Epub 2011 Oct 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk